# Cognitive Behavioral Therapy Reduces Symptom Severity and Normalizes Neurophysiological and Attentional Reactivity in Anorexia Nervosa: A Randomized Controlled Trial

**Authors:** Eda Yılmazer, Metin Çınaroğlu, Selami Varol Ülker, Gökben Hızlı Sayar

PMC · DOI: 10.3390/brainsci16030309 · Brain Sciences · 2026-03-13

## TL;DR

This study shows that cognitive behavioral therapy (CBT) helps reduce symptoms of anorexia nervosa and normalizes brain and attention responses to food and body-related cues.

## Contribution

The first RCT to demonstrate CBT's effects on both self-reported and neurophysiological outcomes in anorexia nervosa.

## Key findings

- CBT significantly reduced eating disorder symptoms and improved emotion regulation compared to a control group.
- CBT participants showed reduced brain activity and attention to body and food cues, indicating physiological changes.
- Symptom improvements were linked to decreased neurophysiological and attentional reactivity.

## Abstract

Background: Anorexia nervosa (AN) is a severe psychiatric disorder marked by restrictive eating, distorted body image, and high relapse rates. While cognitive-behavioral therapy (CBT) is a widely used treatment, its mechanisms of action in AN remain incompletely understood, particularly beyond self-reported symptom change. This study investigated the effects of a 12-week CBT intervention on both clinical and multimodal laboratory-based outcomes in women with restrictive-type AN. Methods: In a two-arm, pre–post randomized controlled trial (ClinicalTrials.gov: NCT07037017), 59 women with restrictive-type AN were randomized to a CBT intervention (n = 30) or no-treatment control (n = 29). A total of 50 participants (CBT: 26; control: 24) completed baseline and post-intervention assessments and were included in analyses. Outcomes included psychometric measures (eating disorder symptoms, depression, anxiety, body image-related obsessive–compulsive symptoms, and cognitive emotion regulation) and laboratory-based indices: electroencephalography (EEG), galvanic skin response (GSR), and eye-tracking during exposure to food- and body-related stimuli. Group × Time effects were analyzed using repeated-measures mixed-effects models, and statistical analyses were conducted using SPSS (Version 31; IBM Corp., Armonk, NY, USA). Results: Significant Group × Time interactions indicated greater improvements in the CBT group across all psychometric outcomes, including reduced eating disorder symptom severity (p < 0.001, ηp2 = 0.28) and increased adaptive emotion regulation. CBT participants also showed significant reductions in EEG P300 and late positive potential (LPP) amplitudes to body-related stimuli, increased frontal alpha asymmetry, decreased visual fixation on salient body and food cues, and attenuated GSR reactivity (all p < 0.05). Exploratory correlations revealed that symptom improvements were associated with reductions in neurophysiological and attentional reactivity. Conclusions: To our knowledge, this is the first RCT in AN to demonstrate that CBT not only improves self-reported outcomes but also modulates neurophysiological and attentional processes implicated in the maintenance of the disorder. Multimodal laboratory assessments provided mechanistic insight into treatment effects and may inform personalized intervention strategies. CBT appears to facilitate recovery through both cognitive–emotional and physiological recalibration.

## Linked entities

- **Diseases:** anorexia nervosa (MONDO:0005351)

## Full-text entities

- **Diseases:** Anxiety (MESH:D001007), bulimia nervosa (MESH:D052018), Eating disorder (MESH:D001068), underweight (MESH:D013851), anorexia (MESH:D000855), fatigue (MESH:D005221), restrictive (MESH:D002313), AOIs (MESH:D001927), Arousal (MESH:D020921), Body Dysmorphic Disorder (MESH:D057215), illness (MESH:D002908), bipolar disorder (MESH:D001714), Weight Concern (MESH:D015431), eye irritation (MESH:D005128), disorder (MESH:D009358), AN (MESH:D000856), weight gain (MESH:D015430), neurological disease (MESH:D020271), neurological impairments (MESH:D009422), binge-eating disorder (MESH:D056912), compulsive checking (MESH:D000073932), cardiovascular, gastrointestinal, and endocrine sequelae (MESH:D005767), compulsive behaviors (MESH:D003193), neurocognitive disturbances (MESH:D019965), BDD (MESH:C562420), psychotic disorders (MESH:D011618), mental disorders (MESH:D001523), organ damage (MESH:D000092124), anxiety disorder (MESH:D001008), OCD (MESH:D009771), substance use disorders (MESH:D019966), mood (MESH:D019964), CBT (MESH:D003072), brain injury (MESH:D001930), Depression (MESH:D003866), malnutrition (MESH:D044342), binge-purge (MESH:D002032), dizziness (MESH:D004244), injury to (MESH:D014947)
- **Chemicals:** caffeine (MESH:D002110), nicotine (MESH:D009538)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024151/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024151/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024151/full.md

---
Source: https://tomesphere.com/paper/PMC13024151